RECOGNITION AND ASSESSMENT
- Presentation of infective endocarditis (IE) is highly variable and can affect almost any organ system
- A high index of suspicion is required in the febrile patient with significant risk factors
- Clinical presentation of IE is changing and classic findings, such as haemorrhagic lesions, are becoming less common.
- Consider a diagnosis of endocarditis in all patients presenting with bacteraemia without an obvious source, especially if the patient has one of the risk factors outlined below
Symptoms and signs
- Non-specific and of insidious onset
- Lethargy
- Nausea, vomiting
- Anorexia, weight loss
- Fever, night sweats
- Shortness of breath
- Musculoskeletal pain
- Haemorrhagic lesions:
- mucocutaneous petechiae
- Janeway lesions (painless, haemorrhagic, macular plaques most frequently seen on palms and soles of feet)
- Roth spots (small, retinal haemorrhages with pale centres, seen near optic nerve)
- splinter haemorrhages
- Anaemia
- Clubbing (if prolonged disease)
- Splenomegaly
- New murmur
- New embolic event which is unexplained
- Discitis
Risk factors
- Previous IE
- Known Valvular heart disease such as:
- aortic regurgitation/stenosis/bicuspid aortic valve
- mitral regurgitation/stenosis/ Rheumatic heart disease
- Prosthetic heart valve
- Intra cardiac device such as pacemaker
- Known congenital heart disease
- patent ductus arteriosus
- atrial and ventricular septal defect
- coarctation of aorta
- complex congenital heart disease
- IV drug use (right sided valve lesions more common)
- Immunosuppressed patients
- Patients with renal failure/dialysis
- Indwelling IV catheter
Blood Cultures
- Aseptic technique is vital. Follow Collection of blood culture specimens guideline
- Draw each sample by separate venepuncture and not from an indwelling catheter
- If patient is IV drug user, or has prosthetic heart valve or central venous catheter, consider fungal cultures. State suspicion of endocarditis on form; blood culture will then be incubated for 3 weeks
- Inform microbiologist of suspected IE
Patient has severe sepsis or septic shock
- Take 2 separate sets of blood cultures and administer empirical antimicrobials within 1 hr of diagnosis
Patient acutely ill
- Take 3 sets of blood cultures at >1 hr intervals within first 24 hr before starting antimicrobial therapy with at least 1 hr interval between each set (one aerobic and one anaerobic bottle per set)
- do not delay antimicrobial therapy in acutely ill patients
Patient not acutely ill
- Take 3 separate sets of blood cultures at >1 hr intervals within first 48 hr
- If patient not acutely ill but antimicrobials have already been commenced, discontinue antimicrobial therapy and take 2 sets of blood cultures daily for 3 days (6 sets)
Other investigations
- FBC and differential WCC:
- look for leucocytosis, usually with neutrophilia
- look for anaemia, usually normochromic normocytic
- ESR
- CRP
- Complement C3, C4, CH50
- ECG, look for conduction defects such as first or second degree block
- Urinalysis, look for protein and microscopic haematuria
- Consider echocardiography in patients on the basis of a balanced clinical assessment by a suitable experienced senior clinician
Diagnostic criteria
- See Duke classification
Table 1: Duke classification in the diagnosis of IE
Definite clinical IE | 2 major clinical criteria (see Table 2) or 1 major and 3 minor criteria or 5 minor criteria (see Table 3) |
---|---|
Probable IE | Clinical findings consistent with IE but fall short of 'definite' and cannot be 'rejected' |
Reject diagnosis | Firm alternative diagnosis for manifestations of IE and resolution of manifestations without antimicrobial therapy or with antimicrobial therapy of ≤4 days |
Table 2: Definitions of Duke major clinical criteria
Major criteria |
---|
1. Positive blood culture for IE
|
2. Evidence of endocardial involvement
|
3. Positive serology for causes of culture negative IE
|
4. Identification of micro-organism from blood or tissue using molecular biology |
Table 3: Definitions of Duke minor clinical criteria
Minor criteria |
---|
1. Predisposition: predisposing heart condition or IV drug use |
2. Fever: temperature >38.0°C |
3. Vascular phenomenon: major arterial emboli, septic pulmonary infarct, mycotic aneurysm, intracranial haemorrhage, conjunctival haemorrhage, Janeway lesions, newly diagnosed clubbing, splinter haemorrhages, splenomegaly |
4. Immunogenic phenomena: glomerulonephritis, Roth spots, RhF +ve, high ESR (>1.5 x upper limit of normal), CRP >100 mg/L |
5. Microbiological evidence: positive blood cultures not meeting definition of major criteria or serological evidence of active organism consistent with IE |
IMMEDIATE TREATMENT
- Once diagnosis confirmed or highly likely based on the Duke classification, refer to the on-call cardiology team to review
- In an ill patient, after blood cultures taken, do not wait for blood culture report or echocardiographic confirmation. Start empirical treatment
Empirical anti-microbial treatment
Penicillin Allergy
- Ask the patient and record what happened when they were given penicillin
- True penicillin allergy is rare
- In IE, alternative antimicrobials are less effective with greater risks attached
- If any doubt about whether patient is truly allergic to penicillin, seek advice from a microbiologist or consultant in infectious diseases
Infection Control alerts
- Check for IC alert
- If IC alert not available, check previous 12 months of microbiology reports
- If MRSA present, treat as tagged for MRSA. See MRSA management
- if ESBL, MGNB, CARB present, treat as tagged for ESBL. See ESBL/MGNB/CARG management
Select antimicrobial treatment for types of endocarditis
- First line: Amoxicillin 2 g IV 4-hrly
- Alternative (true penicillin allergy): Vancomycin IV by infusion (see Vancomycin calculator and guideline)
- Vancomycin (see Vancomycin Vancomycin calculator and guideline)
plus
gentamicin 3 mg/kg IV once daily; see Adjunctive once-daily gentamicin (3 mg/kg) for infective endocarditis - If there are concerns about nephrotoxicity, seek advice from consultant microbiologist/ID
Vancomycin (see Vancomycin calculator and guideline)
plus
meropenem 2 g IV 8-hrly
- Vancomycin (see Vancomycin guideline)
plus gentamicin 3 mg/kg IV. Do not use Gentamicin calculator see Gentamicin guideline - Adjunctive once-daily gentamicin (3 mg/kg) for infective endocarditis
plus rifampicin 600 mg oral (if unable to swallow or absorb oral drugs, IV by infusion) 12-hrly - If there are concerns about nephrotoxicity, seek advice from consultant microbiologist/ID
- Vancomycin (see Vancomycin guideline)
plus gentamicin 3 mg/kg IV. Do not use Gentamicin calculator see Gentamicin guideline - Adjunctive once-daily gentamicin (3 mg/kg) for infective endocarditis
plus rifampicin 600 mg oral (if unable to swallow or absorb oral drugs, IV by infusion) 12-hrly
plus
meropenem 2 g IV 8-hrly - If there are concerns about nephrotoxicity, seek advice from consultant microbiologist/ID
Table 4: Empirical treatment (pending blood culture results)
Type of endocarditis | First line | Alternative (penicillin allergy) |
Native valve - indolent presentation | Amoxicillin 2 g IV 4-hrly | Vancomycin IV by infusion (see Vancomycin calculator and guideline) |
Native valve, severe sepsis (no risk factors for ESBL/multi-resistant enterobacteriacea, Pseudomonas) |
Vancomycin (see Vancomycin calculator and guideline) If there are concerns about nephrotoxicity, seek advice from consultant microbiologist/ID |
|
Native valve, severe sepsis and risk factors for multi-resistant enterobacteriacea, Pseudomonas |
Vancomycin (see Vancomycin calculator and guideline) |
|
Intra-cardiac prosthetic material, or reason to suspect MRSA infection (no risk factors for ESBL/multi-resistant enterobacteriacea, Pseudomonas) |
Vancomycin (see Vancomycin calculator and guideline) If there are concerns about nephrotoxicity, seek advice from consultant microbiologist/ID |
|
Intra-cardiac prosthetic material, or reason to suspect MRSA infection and risk factors for multi-resistant enterobacteriacea, Pseudomonas |
Vancomycin (see Vancomycin calculator and guideline) If there are concerns about nephrotoxicity, seek advice from consultant microbiologist/ID |
SUBSEQUENT MANAGEMENT
- Monitor serum concentrations of vancomycin and gentamicin to avoid toxicity
- Monitor for signs of deafness and balance problems which may occur at normal levels
Culture positive
- Direct choice of antimicrobials by results of blood culture and sensitivity with guidance of a microbiologist and/or infectious diseases consultant
- Treat prosthetic valve endocarditis for at least 6 weeks
Culture negative
- Up to 30% of all cases of IE are blood culture negative
- Failure to culture may be explained by:
- pre-treatment with antimicrobials
- inadequate number/poor quality of samples
- infection with atypical pathogen, (e.g. Chlamydia, Coxiella burnetii, Brucella spp., Bartonella spp, Legionella spp, Tropheryma whipplei)
- infection with a fastidious organism (e.g. members of the HACEK group)
- Continue antimicrobials in definite or probable IE
- In case of cardiac surgery, surgeon to send a tissue from valvular biopsy to microbiology requesting ‘PCR to identify causative organism’
- Take 3 sets of blood cultures at >1 hr intervals within 24 hr with at least 1 hr interval between each set (one aerobic and one anaerobic bottle per set) for indicating on request for prolonged incubation
- In case of previous cardiac surgery, surgeon to send tissue from a valvular biopsy to microbiology requesting 'PCR to identify causative organism including Coxiella burnetii, and Bartonella spp'
- Request antinuclear, anti-phospholipid and anti-pork antibodies
- In patients with negative blood cultures, vegetations, metastatic infection, perivalvular invasion or embolism, consider candida or aspergillus. Consult microbiologist
- Seek opinion of cardiologist and microbiologist for advice on need for serology, culture with special media and subsequent treatment
MONITORING TREATMENT
- ESR can remain raised for up to four weeks
- Temperature usually settles within first 2–4 days, and a subsequent rise may indicate uncontrolled infection but may also indicate antimicrobial resistance, or superinfection with another pathogen
- In cases of aortic valve endocarditis, repeat ECG twice weekly - looking for development of conduction defect (prolonged PR interval) as may signify developing aortic root abscess
- Repeat echocardiogram weekly on cardiology advice
Complications
- Heart failure
- Vegetation embolisation, threatening limbs/organs and/or leading to metastatic abscess (pneumonia/lung abscess in right-sided disease)
- Abscess in aortic valve ring – can produce heart block
- Immune complex disease – vasculitic rash, arthritis, glomerulonephritis
Early surgical intervention indicated
- Decision to undertake valve surgery as part of treatment of infective endocarditis can be extremely challenging. Early consultation will help the timing of surgery – consider an early referral where there is:
- development of heart failure from acute, severe, valvular regurgitation
- evidence of annular or aortic abscess (prolongation of PR interval on daily ECG)
- evidence of significant valve dysfunction and persistent infection after 7–10 days of appropriate antimicrobial treatment
- early prosthetic valve endocarditis (within 2 months of surgery)
- Staph. aureus prosthetic valve endocarditis
- resistant infection, especially associated with prosthetic valve
- fungal endocarditis
- large vegetations (>10 mm)
Endocarditis MDT
A clinician from the team responsible for the patient must:
- Refer patients with suspected or proven infective endocarditis to the on-call cardiology team
- Attend and present patient at the endocarditis MDT
Decisions at MDT
- Diagnosis and further investigations for patients with possible endocarditis or valvular heart disease
- Optimisation/adjustment of antibiotics and other medication
- Follow-up (both in hospital and in primary care)
- Referral for surgery
- Referral for advanced therapies
- Ceilings of care and referral to palliative care
- Referral to other specialities
DISCHARGE AND FOLLOW-UP
- Arrange discharge in consultation with cardiology, infectious diseases and microbiology teams involved. Decision will be based on:
- settling of physical signs
- improvement in appetite
- patient’s sense of wellbeing
- improvement in inflammatory marker (even if still raised)
- Arrange out-patient follow-up in cardiology clinic. Arrange to repeat inflammatory markers and, if possible, echocardiogram before this appointment
- Discuss follow-up with patient. Emphasise need for antimicrobial prophylaxis for future dental and surgical procedures